CHIA and pulmonary fibrosis: Also, dual AMCase and CHIT1 inhibitors, compound 30 described in reference [33] and OATD-01, proved efficacious in HDM-induced pulmonary inflammation and the bleomycin-induced pulmonary fibrosis mice model [28,33].